Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
285.3 USD | +1.17% | +1.13% | -11.69% |
May. 08 | UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating | MT |
May. 08 | RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.69% | 8.03B | |
-4.91% | 182B | |
+1.70% | 110B | |
-2.93% | 68.11B | |
+0.93% | 50.53B | |
+8.72% | 44.8B | |
+2.84% | 40.7B | |
+19.46% | 32.25B | |
+2.37% | 26.53B | |
+15.25% | 25.02B |
- Stock Market
- Equities
- BIO Stock
- News Bio-Rad Laboratories, Inc.
- Bio Rad Laboratories : Citigroup Adjusts Price Target on Bio-Rad Laboratories to $750 From $675, Maintains Buy Rating